These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 21318899

  • 21. Multiple ligand simultaneous docking: orchestrated dancing of ligands in binding sites of protein.
    Li H, Li C.
    J Comput Chem; 2010 Jul 30; 31(10):2014-22. PubMed ID: 20166125
    [Abstract] [Full Text] [Related]

  • 22. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY.
    Drug Discov Today; 2010 Jun 30; 15(11-12):444-50. PubMed ID: 20362693
    [Abstract] [Full Text] [Related]

  • 23. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z, Chuaqui C, Singh J.
    J Med Chem; 2004 Jan 15; 47(2):337-44. PubMed ID: 14711306
    [Abstract] [Full Text] [Related]

  • 24. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M, Proschak E, Kriegl JM, Schneider G.
    Proteomics; 2009 Jan 15; 9(2):451-9. PubMed ID: 19142949
    [Abstract] [Full Text] [Related]

  • 25. Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches.
    Zhu Y, Li HF, Lu S, Zheng YX, Wu Z, Tang WF, Zhou X, Lu T.
    Eur J Med Chem; 2010 May 15; 45(5):1777-91. PubMed ID: 20153566
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
    Rollinger JM, Haupt S, Stuppner H, Langer T.
    J Chem Inf Comput Sci; 2004 May 15; 44(2):480-8. PubMed ID: 15032527
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN, Chen QH, Knaus EE.
    J Med Chem; 2006 Mar 09; 49(5):1668-83. PubMed ID: 16509583
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and biological evaluation of novel pyrazole compounds.
    Youssef AM, Neeland EG, Villanueva EB, White MS, El-Ashmawy IM, Patrick B, Klegeris A, Abd-El-Aziz AS.
    Bioorg Med Chem; 2010 Aug 01; 18(15):5685-96. PubMed ID: 20609589
    [Abstract] [Full Text] [Related]

  • 35. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
    Mason JS, Morize I, Menard PR, Cheney DL, Hulme C, Labaudiniere RF.
    J Med Chem; 1999 Aug 26; 42(17):3251-64. PubMed ID: 10464012
    [Abstract] [Full Text] [Related]

  • 36. Modulation of biomolecular interactions with complex-binding small molecules.
    Cai Z, Greene MI, Berezov A.
    Methods; 2008 Sep 26; 46(1):39-46. PubMed ID: 18571508
    [Abstract] [Full Text] [Related]

  • 37. Ligand coordinate analysis of SC-558 from the active site to the surface of COX-2: a molecular dynamics study.
    Sai Ram KV, Rambabu G, Sarma JA, Desiraju GR.
    J Chem Inf Model; 2006 Sep 26; 46(4):1784-94. PubMed ID: 16859310
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.